A Randomized Phase 2 Trial of Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 25 Dec 2016
At a glance
- Drugs Pazopanib (Primary) ; Diphenhydramine; Temsirolimus
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 16 Mar 2016 Status changed from active, no longer recruiting to recruiting, according to ClinicalTrials.gov record.
- 08 Mar 2016 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 22 Jan 2016 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018 as per ClinicalTrials.gov record.